-
Mashup Score: 0COVID-19 and Cancer Care: Lessons Learned 1 Year Later - 3 year(s) ago
From delayed diagnoses, to the emergence of telemedicine, to managing the increased emotional burden experienced by patients and healthcare professionals alike, the community has been forced to approach cancer care in ways they never had before in light of the COVID-19 pandemic.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0People with Cancer Urged to Get the COVID-19 Vaccine - 3 year(s) ago
The American Association of Cancer Research (AACR) and trusted physicians are urging cancer patients to get the COVID-19 vaccine. Learn more.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Cancer Screening, Diagnosis Rates Nearly Recover to Pre–COVID-19 Levels in the Northeastern United States - 3 year(s) ago
Although cancer screening rates and ensuing diagnoses dropped significantly during the height of the COVID-19 pandemic, testing rates from June 2020 through September 2020 have nearly returned to pre-pandemic levels.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Answers to Your Questions About the COVID-19 Vaccine - 3 year(s) ago
Dr. Julie Gralow, Chief Medical Officer of ASCO, answers common questions and concerns people with cancer have about the COVID-19 vaccines available in the United States.
Source: Cancer.NetCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Oncology Sales Forces Rely on Virtual Meetings During Pandemic - 3 year(s) ago
The COVID-19 pandemic has affected the ability of oncology sales forces to access physicians and advanced practice providers, with fewer face-to-face meetings and fewer interactions overall.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Arutha Kulasinghe, PhD, discusses cancer care during the coronavirus disease 2019 pandemic in Australia.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3It’s Time To Fix The Lack of Diversity in Cancer Clinical Trials - 4 year(s) ago
Stand Up to Cancer’s new initiative aims to increase minority representation in these potentially life-saving trials
Source: MediumCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price. But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interventional radiology allowed him to receive chemotherapy immediately after biopsy, shrinking his tumors dramatically.
Source: CornellCastCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0JNCCN 360 - 4 year(s) ago
By: Jocelyn Solis-Moreira, MS Posted: Friday, April 10, 2020 The journal Blood Advances described reportedly the first successful treatment of a patient with multiple myeloma infected with the 2019 novel coronavirus (COVID-19). Changcheng Zheng, MD, of The First Affiliated Hospital of the University of Science…
Source: jnccn360.orgCategories: Hem/Onc News and JournalsTweet
-
Mashup Score: 0JNCCN 360 - 4 year(s) ago
By: Cordi Craig Posted: Friday, April 10, 2020 The current coronavirus disease 2019 (COVID-19) pandemic has caused uncertainty and unprecedented challenges for the medical community. There is some controversy regarding whether individuals with underlying immunosuppression, such as cancer, are at an increased risk…
Source: jnccn360.orgCategories: Hem/Onc News and JournalsTweet
#COVID-19 and Cancer Care: Lessons Learned 1 Year Later #COVIDandCancer https://t.co/KNFTz4GqWw